Back to Search
Start Over
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone with Carfilzomib in Relapsed or Refractory Multiple Myeloma. Iskpd - IFM2018-03
- Source :
- 64th ASH Annual Meeting and Exposition, 64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.4452-4453, ⟨10.1182/blood-2022-166870⟩
- Publication Year :
- 2022
- Publisher :
- HAL CCSD, 2022.
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- 64th ASH Annual Meeting and Exposition, 64th ASH Annual Meeting and Exposition, Dec 2022, New Orleans, United States. pp.4452-4453, ⟨10.1182/blood-2022-166870⟩
- Accession number :
- edsair.doi.dedup.....622a5132e5389f2ceb71421d5155f7ae
- Full Text :
- https://doi.org/10.1182/blood-2022-166870⟩